{"transactions":[{"id":729166,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-23T22:51:03.000Z","date":"2026-06-19","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares shall vest on each of the next forty-eight (48) monthly anniversaries of the grant date with partial acceleration tied to certain performance milestones, provided that the Reporting Person maintains a service relationship with the Issuer as of the applicable vesting dates."}],"balance_after":55000,"derivative":{"exercise_price":8.1,"expiration_date":"2036-06-18","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001340875-26-000007","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000134087526000007/ownership.xml","form_type":"4"}},{"id":763384,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-26T20:14:29.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":15508,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted stock units (\"RSUs\") pursuant to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan, as amended. RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest 100% on May 21, 2027; however, delivery of the shares is deferred until the earlier of (a) the date of the director's separation from service to Karyopharm Therapeutics Inc. and (b) a change-in-control event."}],"balance_after":15508,"source":{"system":"sec-edgar","filing":"0001340875-26-000005","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1340875/000134087526000005/ownership.xml","form_type":"4"}},{"id":826393,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-27T20:12:24.000Z","date":"2026-03-25","kind":"grant","planned":false,"acquired":true,"shares":468555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"(1) 1/48th of the shares shall vest on each of the next forty-eight (48) monthly anniversaries of the grant date, provided that the Reporting Person maintains a service relationship with the Issuer as of the applicable vesting dates."}],"balance_after":468555,"derivative":{"exercise_price":6.81,"expiration_date":"2036-03-24","underlying":"Common Stock","underlying_shares":468555},"source":{"system":"sec-edgar","filing":"0001340875-26-000003","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000134087526000003/ownership.xml","form_type":"4"}},{"id":930071,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-01-27T21:45:07.000Z","date":"2026-01-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":1755,"price":8.44,"value":14812.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units and does not represent a sale by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects a 1-for-16 reverse stock split effected by the Issuer on December 30, 2025."}],"balance_after":6820,"source":{"system":"sec-edgar","filing":"0001193125-26-024749","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000119312526024749/ownership.xml","form_type":"4"}},{"id":1130353,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2025-05-29T20:07:05.000Z","date":"2025-05-28","kind":"grant","planned":false,"acquired":true,"shares":4600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Amounts reported in this Form 4 reflect the one-for-fifteen reverse stock split effected by the Issuer on February 25, 2025."},{"field":"shares","element":"transactionShares","label":"F1","text":"Amounts reported in this Form 4 reflect the one-for-fifteen reverse stock split effected by the Issuer on February 25, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests as to 100% of the underlying shares on May 28, 2026."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Amounts reported in this Form 4 reflect the one-for-fifteen reverse stock split effected by the Issuer on February 25, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amounts reported in this Form 4 reflect the one-for-fifteen reverse stock split effected by the Issuer on February 25, 2025."}],"balance_after":4600,"derivative":{"exercise_price":4.48,"expiration_date":"2035-05-27","underlying":"Common Stock","underlying_shares":4600},"source":{"system":"sec-edgar","filing":"0000950170-25-078938","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1340875/000095017025078938/ownership.xml","form_type":"4"}},{"id":1284934,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-04T21:41:56.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":763829,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares shall vest on each of the next forty-eight (48) monthly anniversaries of the grant date, provided that the Reporting Person maintains a service relationship with the Issuer as of the applicable vesting dates."}],"balance_after":763829,"derivative":{"exercise_price":0.885,"expiration_date":"2035-01-30","underlying":"Common Stock","underlying_shares":763829},"source":{"system":"sec-edgar","filing":"0000950170-25-013607","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000095017025013607/ownership.xml","form_type":"4"}},{"id":1293100,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-01-28T21:29:04.000Z","date":"2025-01-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":28101,"price":0.9218,"value":25903.5018,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units and does not represent a sale by the Reporting Person."}],"balance_after":137201,"source":{"system":"sec-edgar","filing":"0000950170-25-009843","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000095017025009843/ownership.xml","form_type":"4"}},{"id":1486854,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T20:09:05.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":1770427,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares shall vest in forty-eight (48) equal monthly installaments following January 26, 2024, provided that the Reporting Person maintains a service relationship with the Issuer as of the applicable vesting dates."}],"balance_after":1770427,"derivative":{"exercise_price":2.53,"expiration_date":"2034-01-25","underlying":"Common Stock","underlying_shares":1770427},"source":{"system":"sec-edgar","filing":"0000950170-24-070618","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000095017024070618/ownership.xml","form_type":"4"}},{"id":1497608,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2024-05-30T21:32:35.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":69000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 100% of the underlying shares on May 29, 2025."}],"balance_after":69000,"derivative":{"exercise_price":0.96,"expiration_date":"2034-05-28","underlying":"Common Stock","underlying_shares":69000},"source":{"system":"sec-edgar","filing":"0000950170-24-066786","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1340875/000095017024066786/ownership.xml","form_type":"4"}},{"id":1669576,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-27T00:06:45.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":1116903,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/48th of the shares shall vest on each of the next forty-eight (48) monthly anniversaries of the grant date, provided that the Reporting Person maintains a service relationship with the Issuer as of the applicable vesting dates."}],"balance_after":1116903,"derivative":{"exercise_price":2.4,"expiration_date":"2034-01-23","underlying":"Common Stock","underlying_shares":1116903},"source":{"system":"sec-edgar","filing":"0000950170-24-008046","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000095017024008046/ownership.xml","form_type":"4"}},{"id":1669575,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-01-27T00:06:45.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":70300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Reporting Person was issued RSUs. Each RSU represents a contingent right to receive one share of Common Stock. The RSUs shall vest in three (3) annual installments, with the first tranche vesting on January 24, 2025. The RSUs may be settled only by delivering shares of Common Stock, and thus, the grant is being reported in Table I as allowed per SEC guidance."}],"balance_after":208771,"source":{"system":"sec-edgar","filing":"0000950170-24-008046","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000095017024008046/ownership.xml","form_type":"4"}},{"id":1669574,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-01-27T00:06:45.000Z","date":"2024-01-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":15290,"price":2.4,"value":36696.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units and does not represent a sale by the Reporting Person."}],"balance_after":138471,"source":{"system":"sec-edgar","filing":"0000950170-24-008046","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000095017024008046/ownership.xml","form_type":"4"}},{"id":1770493,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-10-03T00:16:14.000Z","date":"2023-10-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":23208,"price":1.37,"value":31794.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units and does not represent a sale by the Reporting Person."}],"balance_after":153761,"source":{"system":"sec-edgar","filing":"0001209191-23-051259","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919123051259/doc4.xml","form_type":"4"}},{"id":1770492,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-10-03T00:16:14.000Z","date":"2023-10-02","kind":"purchase","planned":false,"acquired":true,"shares":5500,"price":1.3345,"value":7339.75,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"). The Reporting Person will promptly and voluntarily disgorge to the Issuer the full amount of the resulting statutory profit calculated pursuant to Section 16(b) of the Exchange Act."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions in prices ranging from $1.32 to $1.35, inclusive. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents shares held directly by The I. Schor IRRV Trust, an irrevocable family trust having an independent trustee."}],"balance_after":43469,"source":{"system":"sec-edgar","filing":"0001209191-23-051259","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919123051259/doc4.xml","form_type":"4"}},{"id":1770491,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-10-03T00:16:14.000Z","date":"2023-09-29","kind":"sale","planned":false,"acquired":false,"shares":5500,"price":1.3601,"value":7480.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"). The Reporting Person will promptly and voluntarily disgorge to the Issuer the full amount of the resulting statutory profit calculated pursuant to Section 16(b) of the Exchange Act."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $1.33 to $1.38, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Securities and Exchange Commission (\"SEC\") staff upon request."}],"balance_after":176969,"source":{"system":"sec-edgar","filing":"0001209191-23-051259","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919123051259/doc4.xml","form_type":"4"}},{"id":1770490,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-10-03T00:16:14.000Z","date":"2023-09-28","kind":"purchase","planned":false,"acquired":true,"shares":5500,"price":1.42,"value":7810.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"). The Reporting Person will promptly and voluntarily disgorge to the Issuer the full amount of the resulting statutory profit calculated pursuant to Section 16(b) of the Exchange Act."}],"balance_after":182469,"source":{"system":"sec-edgar","filing":"0001209191-23-051259","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919123051259/doc4.xml","form_type":"4"}},{"id":1770489,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-10-03T00:16:14.000Z","date":"2023-09-28","kind":"sale","planned":false,"acquired":false,"shares":5500,"price":1.42,"value":7810.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"). The Reporting Person will promptly and voluntarily disgorge to the Issuer the full amount of the resulting statutory profit calculated pursuant to Section 16(b) of the Exchange Act."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents shares held directly by The I. Schor IRRV Trust, an irrevocable family trust having an independent trustee."}],"balance_after":37969,"source":{"system":"sec-edgar","filing":"0001209191-23-051259","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919123051259/doc4.xml","form_type":"4"}},{"id":1805924,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-16T22:11:59.000Z","date":"2023-08-14","kind":"grant","planned":false,"acquired":true,"shares":384900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The exercise price of the option is $2.14 per share, representing the fair market value per share of the Issuer's Common Stock on the Effective Date; provided that the repriced option will revert to its original exercise price if, prior to the first anniversary of the Effective Date, (a) the Reporting Person's employment is terminated by the Issuer with cause or by the Reporting Person or (b) the option is exercised."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 14, 2023 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 14, 2023 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The shares subject to this option shall vest in forty-eight (48) equal installments on each monthly anniversary following January 24, 2023, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":384900,"derivative":{"exercise_price":2.14,"expiration_date":"2033-01-23","underlying":"Common Stock","underlying_shares":384900},"source":{"system":"sec-edgar","filing":"0001209191-23-046103","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919123046103/doc4.xml","form_type":"4"}},{"id":1805923,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-16T22:11:59.000Z","date":"2023-08-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":384900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 14, 2023 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 14, 2023 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The shares subject to this option shall vest in forty-eight (48) equal installments on each monthly anniversary following January 24, 2023, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":9.05,"expiration_date":"2033-01-23","underlying":"Common Stock","underlying_shares":384900},"source":{"system":"sec-edgar","filing":"0001209191-23-046103","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919123046103/doc4.xml","form_type":"4"}},{"id":1805922,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-16T22:11:59.000Z","date":"2023-08-14","kind":"grant","planned":false,"acquired":true,"shares":295000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The exercise price of the option is $2.14 per share, representing the fair market value per share of the Issuer's Common Stock on the Effective Date; provided that the repriced option will revert to its original exercise price if, prior to the first anniversary of the Effective Date, (a) the Reporting Person's employment is terminated by the Issuer with cause or by the Reporting Person or (b) the option is exercised."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 14, 2023 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 14, 2023 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The shares subject to this option shall vest in forty-eight (48) equal installments on each monthly anniversary following January 7, 2022, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":295000,"derivative":{"exercise_price":2.14,"expiration_date":"2032-01-06","underlying":"Common Stock","underlying_shares":295000},"source":{"system":"sec-edgar","filing":"0001209191-23-046103","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919123046103/doc4.xml","form_type":"4"}},{"id":1805921,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-16T22:11:59.000Z","date":"2023-08-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":295000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 14, 2023 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 14, 2023 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The shares subject to this option shall vest in forty-eight (48) equal installments on each monthly anniversary following January 7, 2022, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":15.52,"expiration_date":"2032-01-06","underlying":"Common Stock","underlying_shares":295000},"source":{"system":"sec-edgar","filing":"0001209191-23-046103","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919123046103/doc4.xml","form_type":"4"}},{"id":1805920,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-16T22:11:59.000Z","date":"2023-08-14","kind":"grant","planned":false,"acquired":true,"shares":421600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The exercise price of the option is $2.14 per share, representing the fair market value per share of the Issuer's Common Stock on the Effective Date; provided that the repriced option will revert to its original exercise price if, prior to the first anniversary of the Effective Date, (a) the Reporting Person's employment is terminated by the Issuer with cause or by the Reporting Person or (b) the option is exercised."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 14, 2023 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 14, 2023 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares subject to this option shall vest in forty-eight (48) equal installments on each monthly anniversary following February 12, 2021, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":421600,"derivative":{"exercise_price":2.14,"expiration_date":"2031-02-11","underlying":"Common Stock","underlying_shares":421600},"source":{"system":"sec-edgar","filing":"0001209191-23-046103","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919123046103/doc4.xml","form_type":"4"}},{"id":1805919,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-16T22:11:59.000Z","date":"2023-08-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":421600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 14, 2023 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 14, 2023 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares subject to this option shall vest in forty-eight (48) equal installments on each monthly anniversary following February 12, 2021, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":16.82,"expiration_date":"2031-02-11","underlying":"Common Stock","underlying_shares":421600},"source":{"system":"sec-edgar","filing":"0001209191-23-046103","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919123046103/doc4.xml","form_type":"4"}},{"id":1805918,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-16T22:11:59.000Z","date":"2023-08-14","kind":"grant","planned":false,"acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The exercise price of the option is $2.14 per share, representing the fair market value per share of the Issuer's Common Stock on the Effective Date; provided that the repriced option will revert to its original exercise price if, prior to the first anniversary of the Effective Date, (a) the Reporting Person's employment is terminated by the Issuer with cause or by the Reporting Person or (b) the option is exercised."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 14, 2023 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 14, 2023 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to this option shall vest in forty-eight (48) equal installments on each monthly anniversary following January 13, 2021, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":240000,"derivative":{"exercise_price":2.14,"expiration_date":"2031-01-12","underlying":"Common Stock","underlying_shares":240000},"source":{"system":"sec-edgar","filing":"0001209191-23-046103","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919123046103/doc4.xml","form_type":"4"}},{"id":1805917,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-16T22:11:59.000Z","date":"2023-08-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 14, 2023 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 14, 2023 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to this option shall vest in forty-eight (48) equal installments on each monthly anniversary following January 13, 2021, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":13.27,"expiration_date":"2031-01-12","underlying":"Common Stock","underlying_shares":240000},"source":{"system":"sec-edgar","filing":"0001209191-23-046103","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919123046103/doc4.xml","form_type":"4"}},{"id":1805916,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-16T22:11:59.000Z","date":"2023-08-14","kind":"grant","planned":false,"acquired":true,"shares":872111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The exercise price of the option is $2.14 per share, representing the fair market value per share of the Issuer's Common Stock on the Effective Date; provided that the repriced option will revert to its original exercise price if, prior to the first anniversary of the Effective Date, (a) the Reporting Person's employment is terminated by the Issuer with cause or by the Reporting Person or (b) the option is exercised."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 14, 2023 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 14, 2023 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to this option shall vest in forty-eight (48) equal installments on each monthly anniversary following September 17, 2020, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":872111,"derivative":{"exercise_price":2.14,"expiration_date":"2030-09-16","underlying":"Common Stock","underlying_shares":872111},"source":{"system":"sec-edgar","filing":"0001209191-23-046103","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919123046103/doc4.xml","form_type":"4"}},{"id":1805915,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-16T22:11:59.000Z","date":"2023-08-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":872111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 14, 2023 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 14, 2023 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to this option shall vest in forty-eight (48) equal installments on each monthly anniversary following September 17, 2020, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":16.11,"expiration_date":"2030-09-16","underlying":"Common Stock","underlying_shares":872111},"source":{"system":"sec-edgar","filing":"0001209191-23-046103","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919123046103/doc4.xml","form_type":"4"}},{"id":1805914,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-16T22:11:59.000Z","date":"2023-08-14","kind":"grant","planned":false,"acquired":true,"shares":36857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The exercise price of the option is $2.14 per share, representing the fair market value per share of the Issuer's Common Stock on the Effective Date; provided that the repriced option will revert to its original exercise price if, prior to the first anniversary of the Effective Date, (a) the Reporting Person's employment is terminated by the Issuer with cause or by the Reporting Person or (b) the option is exercised."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 14, 2023 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 14, 2023 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option are fully vested and exercisable as of the date hereof."}],"balance_after":36857,"derivative":{"exercise_price":2.14,"expiration_date":"2029-12-05","underlying":"Common Stock","underlying_shares":36857},"source":{"system":"sec-edgar","filing":"0001209191-23-046103","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919123046103/doc4.xml","form_type":"4"}},{"id":1805913,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-16T22:11:59.000Z","date":"2023-08-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":36857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects 1-for-7 reverse stock split effected by the Issuer on September 15, 2020."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 14, 2023 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects 1-for-7 reverse stock split effected by the Issuer on September 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 14, 2023 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option are fully vested and exercisable as of the date hereof."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects 1-for-7 reverse stock split effected by the Issuer on September 15, 2020."}],"balance_after":0,"derivative":{"exercise_price":8.89,"expiration_date":"2029-12-05","underlying":"Common Stock","underlying_shares":36857},"source":{"system":"sec-edgar","filing":"0001209191-23-046103","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919123046103/doc4.xml","form_type":"4"}},{"id":1877766,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2023-05-25T20:11:34.000Z","date":"2023-05-24","kind":"grant","planned":false,"acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 100% of the underlying shares on May 24, 2024."}],"balance_after":34000,"derivative":{"exercise_price":2.5,"expiration_date":"2033-05-23","underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001209191-23-032152","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1340875/000120919123032152/doc4.xml","form_type":"4"}},{"id":2016535,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-02-15T02:09:43.000Z","date":"2022-11-14","kind":"gift","acquired":true,"shares":9955,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":48000,"source":{"system":"sec-edgar","filing":"0001209191-23-009588","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919123009588/doc5.xml","form_type":"5"}},{"id":2016534,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-02-15T02:09:43.000Z","date":"2022-11-14","kind":"gift","acquired":false,"shares":9955,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents shares held directly by The I. Schor IRRV Trust, an irrevocable family trust having an independent trustee."}],"balance_after":43469,"source":{"system":"sec-edgar","filing":"0001209191-23-009588","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919123009588/doc5.xml","form_type":"5"}},{"id":2016533,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-02-15T02:09:43.000Z","date":"2022-10-17","kind":"gift","acquired":true,"shares":26712,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents shares held directly by The I. Schor IRRV Trust, an irrevocable family trust having an independent trustee."}],"balance_after":53424,"source":{"system":"sec-edgar","filing":"0001209191-23-009588","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919123009588/doc5.xml","form_type":"5"}},{"id":2016532,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-02-15T02:09:43.000Z","date":"2022-10-17","kind":"gift","acquired":false,"shares":26712,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":38045,"source":{"system":"sec-edgar","filing":"0001209191-23-009588","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919123009588/doc5.xml","form_type":"5"}},{"id":2016531,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-02-15T02:09:43.000Z","date":"2022-09-28","kind":"gift","acquired":true,"shares":26712,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents shares held directly by The I. Schor IRRV Trust, an irrevocable family trust having an independent trustee."}],"balance_after":26712,"source":{"system":"sec-edgar","filing":"0001209191-23-009588","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919123009588/doc5.xml","form_type":"5"}},{"id":2016530,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-02-15T02:09:43.000Z","date":"2022-09-28","kind":"gift","acquired":false,"shares":26712,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":64757,"source":{"system":"sec-edgar","filing":"0001209191-23-009588","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919123009588/doc5.xml","form_type":"5"}},{"id":2016529,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-02-15T02:09:43.000Z","date":"2022-09-27","kind":"gift","acquired":true,"shares":26712,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":91469,"source":{"system":"sec-edgar","filing":"0001209191-23-009588","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919123009588/doc5.xml","form_type":"5"}},{"id":2016528,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-02-15T02:09:43.000Z","date":"2022-09-27","kind":"gift","acquired":false,"shares":26712,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents shares held directly by The I. Schor IRRV Trust, an irrevocable family trust having an independent trustee."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-009588","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919123009588/doc5.xml","form_type":"5"}},{"id":2016527,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-02-15T02:09:43.000Z","date":"2022-09-13","kind":"gift","acquired":true,"shares":26712,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents shares held directly by The I. Schor IRRV Trust, an irrevocable family trust having an independent trustee."}],"balance_after":26712,"source":{"system":"sec-edgar","filing":"0001209191-23-009588","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919123009588/doc5.xml","form_type":"5"}},{"id":2016526,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-02-15T02:09:43.000Z","date":"2022-09-13","kind":"gift","acquired":false,"shares":26712,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":64757,"source":{"system":"sec-edgar","filing":"0001209191-23-009588","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919123009588/doc5.xml","form_type":"5"}},{"id":2045049,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-26T21:05:32.000Z","date":"2023-01-24","kind":"grant","acquired":true,"shares":384900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48th of the shares shall vest on each of the next forty-eight (48) monthly anniversaries of the grant date, provided that the Reporting Person maintains a service relationship with the Company as of the applicable vesting dates."}],"balance_after":384900,"derivative":{"exercise_price":9.05,"expiration_date":"2033-01-23","underlying":"Common Stock","underlying_shares":384900},"source":{"system":"sec-edgar","filing":"0001209191-23-005033","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919123005033/doc4.xml","form_type":"4"}},{"id":2045048,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-01-26T21:05:32.000Z","date":"2023-01-24","kind":"grant","acquired":true,"shares":85500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was issued Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs shall vest in three (3) annual installments, with the first tranche vesting on January 24, 2024. The RSUs may be settled only by delivering shares of Common Stock, and thus, the grant is being reported in Table I as allowed per SEC guidance."}],"balance_after":176969,"source":{"system":"sec-edgar","filing":"0001209191-23-005033","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919123005033/doc4.xml","form_type":"4"}},{"id":2116219,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-11-15T21:31:16.000Z","date":"2022-11-10","kind":"sale","acquired":false,"shares":30000,"price":20.064,"value":601920.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $20.00 to $20.27, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents shares held directly by The C. Schor IRRV Trust, an irrevocable family trust having an independent trustee."}],"balance_after":53424,"source":{"system":"sec-edgar","filing":"0001209191-22-057004","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919122057004/doc4.xml","form_type":"4"}},{"id":2116218,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-11-15T21:31:16.000Z","date":"2022-11-10","kind":"sale","acquired":false,"shares":9955,"price":21.0268,"value":209321.794,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $21.00 to $21.18, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Securities and Exchange Commission (\"SEC\") staff upon request."}],"balance_after":91469,"source":{"system":"sec-edgar","filing":"0001209191-22-057004","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919122057004/doc4.xml","form_type":"4"}},{"id":2121222,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-11-09T21:05:15.000Z","date":"2022-11-07","kind":"sale","acquired":false,"shares":30000,"price":19.0496,"value":571488.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $19.00 to $19.24, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Securities and Exchange Commission staff upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents shares held directly by The C. Schor IRRV Trust, an irrevocable family trust having an independent trustee."}],"balance_after":83424,"source":{"system":"sec-edgar","filing":"0001209191-22-056193","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919122056193/doc4.xml","form_type":"4"}},{"id":2124481,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-11-04T21:23:45.000Z","date":"2022-11-03","kind":"sale","acquired":false,"shares":24813,"price":18.0437,"value":447718.3281,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $18.00 to $18.25, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Securities and Exchange Commission staff upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents shares held directly by The C. Schor IRRV Trust, an irrevocable family trust having an independent trustee."}],"balance_after":113424,"source":{"system":"sec-edgar","filing":"0001209191-22-055828","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919122055828/doc4.xml","form_type":"4"}},{"id":2124480,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-11-04T21:23:45.000Z","date":"2022-11-02","kind":"sale","acquired":false,"shares":500,"price":18,"value":9000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents shares held directly by The C. Schor IRRV Trust, an irrevocable family trust having an independent trustee."}],"balance_after":138237,"source":{"system":"sec-edgar","filing":"0001209191-22-055828","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919122055828/doc4.xml","form_type":"4"}},{"id":2144779,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-10-04T21:22:55.000Z","date":"2022-10-04","kind":"tax_withholding","acquired":false,"shares":21288,"price":14.22,"value":302715.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units and does not represent a sale by the Reporting Person."}],"balance_after":101424,"source":{"system":"sec-edgar","filing":"0001209191-22-052383","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919122052383/doc4.xml","form_type":"4"}},{"id":2157404,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-09-16T21:51:04.000Z","date":"2022-09-14","kind":"sale","acquired":false,"shares":952,"price":18,"value":17136.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents shares held directly by The C. Schor IRRV Trust, an irrevocable family trust having an independent trustee."}],"balance_after":138737,"source":{"system":"sec-edgar","filing":"0001209191-22-050372","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919122050372/doc4.xml","form_type":"4"}},{"id":2160182,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-09-13T20:59:56.000Z","date":"2022-09-13","kind":"sale","acquired":false,"shares":3371,"price":18.0105,"value":60713.3955,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $18.00 to $18.05, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents shares held directly by The C. Schor IRRV Trust, an irrevocable family trust having an independent trustee."}],"balance_after":139689,"source":{"system":"sec-edgar","filing":"0001209191-22-049721","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919122049721/doc4.xml","form_type":"4"}},{"id":2160181,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-09-13T20:59:56.000Z","date":"2022-09-12","kind":"sale","acquired":false,"shares":200,"price":18,"value":3600.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents shares held directly by The C. Schor IRRV Trust, an irrevocable family trust having an independent trustee."}],"balance_after":143060,"source":{"system":"sec-edgar","filing":"0001209191-22-049721","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919122049721/doc4.xml","form_type":"4"}},{"id":2160180,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-09-13T20:59:56.000Z","date":"2022-09-12","kind":"sale","acquired":false,"shares":66747,"price":16.7694,"value":1119307.1418,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $16.50 to $16.96, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents shares held directly by The I. Schor IRRV Trust, an irrevocable family trust having an independent trustee."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-049721","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919122049721/doc4.xml","form_type":"4"}},{"id":2160179,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-09-13T20:59:56.000Z","date":"2022-09-09","kind":"sale","acquired":false,"shares":8094,"price":16.5062,"value":133601.1828,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $16.50 to $16.56, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Securities and Exchange Commission (\"SEC\") staff upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents shares held directly by The I. Schor IRRV Trust, an irrevocable family trust having an independent trustee."}],"balance_after":66747,"source":{"system":"sec-edgar","filing":"0001209191-22-049721","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919122049721/doc4.xml","form_type":"4"}},{"id":2191985,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-08-09T00:32:56.000Z","date":"2022-08-04","kind":"tax_withholding","acquired":false,"shares":21288,"price":18.25,"value":388506.0,"ownership":{"direct":true},"balance_after":122712,"source":{"system":"sec-edgar","filing":"0001209191-22-044905","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919122044905/doc4.xml","form_type":"4"}},{"id":2191984,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-08-09T00:32:56.000Z","date":"2022-08-04","kind":"grant","acquired":true,"shares":48000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Reporting Person was issued 240,000 Restricted Stock Units (\"RSUs\") on October 1, 2021, as previously reported on a Form 4 filed by the Reporting Person on October 5, 2021. Each RSU represents a contingent right to receive one share of common stock. A total of 96,000 of the RSUs shall vest in two (2) annual installments of 20% of the shares vesting, with the first tranche vesting on October 1, 2022 and the second tranche vesting on October 1, 2023. A total of 144,000 of the RSUs shall vest upon achievements of specific milestones outlined in the Reporting Person's Restricted Stock Unit Agreement. On August 4, 2022, upon the occurrence of the third performance milestone, 48,000 of the RSUs vested. The RSUs may be settled only by delivering shares of common stock, and thus, the grant is being reported in Table I as allowed per SEC guidance."}],"balance_after":144000,"source":{"system":"sec-edgar","filing":"0001209191-22-044905","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919122044905/doc4.xml","form_type":"4"}},{"id":2191983,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-08-09T00:32:56.000Z","date":"2022-07-06","kind":"gift","acquired":true,"shares":53424,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the transfer of shares held by the Reporting Person to The C. Schor IRRV Trust for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents shares held directly by The C. Schor IRRV Trust, an irrevocable family trust having an independent trustee."}],"balance_after":143260,"source":{"system":"sec-edgar","filing":"0001209191-22-044905","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919122044905/doc4.xml","form_type":"4"}},{"id":2191982,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-08-09T00:32:56.000Z","date":"2022-07-06","kind":"gift","acquired":false,"shares":53424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the transfer of shares held by the Reporting Person to The C. Schor IRRV Trust for no consideration."}],"balance_after":96000,"source":{"system":"sec-edgar","filing":"0001209191-22-044905","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919122044905/doc4.xml","form_type":"4"}},{"id":2261509,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2022-05-20T20:12:05.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":23900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 100% of the underlying shares on the earlier of May 19, 2023 or the next annual meeting of stockholders of Karyopharm Therapeutics Inc."}],"balance_after":23900,"derivative":{"exercise_price":5.65,"expiration_date":"2032-05-18","underlying":"Common Stock","underlying_shares":23900},"source":{"system":"sec-edgar","filing":"0001209191-22-030986","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1340875/000120919122030986/doc4.xml","form_type":"4"}},{"id":2391962,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-02-17T02:31:54.000Z","date":"2022-02-14","kind":"tax_withholding","acquired":false,"shares":21288,"price":14.27,"value":303779.76,"ownership":{"direct":true},"balance_after":149424,"source":{"system":"sec-edgar","filing":"0001209191-22-010475","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919122010475/doc4.xml","form_type":"4"}},{"id":2391961,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-02-17T02:31:54.000Z","date":"2022-02-14","kind":"grant","acquired":true,"shares":48000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Reporting Person was issued 240,000 Restricted Stock Units (\"RSUs\") on October 1, 2021, as previously reported on a Form 4 filed by the Reporting Person on October 5, 2021. Each RSU represents a contingent right to receive one share of common stock. A total of 96,000 of the RSUs shall vest in two (2) annual installments of 20% of the shares vesting, with the first tranche vesting on October 1, 2022 and the second tranche vesting on October 1, 2023. A total of 144,000 of the RSUs shall vest upon achievements of specific milestones outlined in the Reporting Persons Restricted Stock Unit Agreement. On February 14, 2022, upon the occurrence of the second performance milestone, 48,000 of the RSUs vested. The RSUs may be settled only by delivering shares of common stock, and thus, the grant is being reported in Table I as allowed per SEC guidance."}],"balance_after":170712,"source":{"system":"sec-edgar","filing":"0001209191-22-010475","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919122010475/doc4.xml","form_type":"4"}},{"id":2419357,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-02-02T01:40:56.000Z","date":"2022-01-28","kind":"tax_withholding","acquired":false,"shares":21288,"price":11.69,"value":248856.72,"ownership":{"direct":true},"balance_after":122712,"source":{"system":"sec-edgar","filing":"0001209191-22-006132","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919122006132/doc4.xml","form_type":"4"}},{"id":2419356,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-02-02T01:40:56.000Z","date":"2022-01-28","kind":"grant","acquired":true,"shares":48000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Reporting Person was issued 240,000 Restricted Stock Units (\"RSUs\") on October 1, 2021, as previously reported on a Form 4 filed by the Reporting Person on October 5, 2021. Each RSU represents a contingent right to receive one share of common stock. A total of 96,000 of the RSUs shall vest in two (2) annual installments of 20% of the shares vesting, with the first tranche vesting on October 1, 2022 and the second tranche vesting on October 1, 2023. A total of 144,000 of the RSUs shall vest upon achievements of specific milestones outlined in the Reporting Persons Restricted Stock Unit Agreement. On January 28, 2022, upon the occurrence of the first performance milestone, 48,000 of the RSUs vested. The RSUs may be settled only by delivering shares of common stock, and thus, the grant is being reported in Table I as allowed per SEC guidance."}],"balance_after":144000,"source":{"system":"sec-edgar","filing":"0001209191-22-006132","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919122006132/doc4.xml","form_type":"4"}},{"id":2437794,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-11T21:28:34.000Z","date":"2022-01-07","kind":"grant","acquired":true,"shares":295000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares shall vest on each of the next forty-eight (48) monthly anniversaries of the Grant Date, provided that the Reporting Person maintains a service relationship with the Company as of the applicable vesting dates."}],"balance_after":295000,"derivative":{"exercise_price":15.52,"expiration_date":"2032-01-06","underlying":"Common Stock","underlying_shares":295000},"source":{"system":"sec-edgar","filing":"0001209191-22-002860","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919122002860/doc4.xml","form_type":"4"}},{"id":2549087,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-10-05T21:14:14.000Z","date":"2021-10-01","kind":"grant","acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was issued Restricted Stock Units (\"RSU\"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest in two (2) annual installments of 20% of the shares vesting, with the first tranche vesting on October 1, 2022 and the second tranche vesting on October 1, 2023.  The remaining shares shall vest upon achievements of specific milestones outlined in the Reporting Persons Restricted Stock Unit Agreement.  The RSUs may be settled only by delivering shares of common stock, and thus, the grant is being reported in Table I as allowed per SEC guidance."}],"balance_after":240000,"source":{"system":"sec-edgar","filing":"0001209191-21-059577","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919121059577/doc4.xml","form_type":"4"}},{"id":2661215,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-06-21T20:25:29.000Z","date":"2021-06-16","kind":"sale","acquired":false,"shares":8982,"price":10.5334,"value":94610.9988,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $10.32 to $10.86, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents shares held directly by an irrevocable family trust having an independent trustee."}],"balance_after":89836,"source":{"system":"sec-edgar","filing":"0001209191-21-042000","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919121042000/doc4.xml","form_type":"4"}},{"id":2661214,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-06-21T20:25:29.000Z","date":"2021-06-16","kind":"sale","acquired":false,"shares":7484,"price":10.5334,"value":78831.9656,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $10.32 to $10.86, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents shares held directly by an irrevocable family trust having an independent trustee."}],"balance_after":74841,"source":{"system":"sec-edgar","filing":"0001209191-21-042000","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919121042000/doc4.xml","form_type":"4"}},{"id":2679402,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-06-07T23:12:06.000Z","date":"2021-06-03","kind":"sale","acquired":false,"shares":8982,"price":12.0551,"value":108278.9082,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $11.60 to $12.39, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents shares held directly by an irrevocable family trust having an independent trustee."}],"balance_after":98818,"source":{"system":"sec-edgar","filing":"0001209191-21-038758","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919121038758/doc4.xml","form_type":"4"}},{"id":2679401,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-06-07T23:12:06.000Z","date":"2021-06-03","kind":"sale","acquired":false,"shares":7484,"price":12.0551,"value":90220.3684,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $11.60 to $12.39, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents shares held directly by an irrevocable family trust having an independent trustee."}],"balance_after":82325,"source":{"system":"sec-edgar","filing":"0001209191-21-038758","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919121038758/doc4.xml","form_type":"4"}},{"id":2700498,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2021-05-21T21:36:30.000Z","date":"2021-05-21","kind":"grant","acquired":true,"shares":23900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 100% of the underlying shares on the earlier of May 21, 2022 or the next annual meeting of stockholders of Karyopharm Therapeutics Inc. (the \"Issuer\"), provided that the reporting person continues to serve as a director of the Issuer through such date."}],"balance_after":23900,"derivative":{"exercise_price":9.42,"expiration_date":"2031-05-20","underlying":"Common Stock","underlying_shares":23900},"source":{"system":"sec-edgar","filing":"0001209191-21-035031","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1340875/000120919121035031/doc4.xml","form_type":"4"}},{"id":2700986,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-05-21T20:34:09.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":733,"price":13.7277,"value":10062.4041,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $13.69 to $13.79, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents shares held directly by an irrevocable family trust having an independent trustee."}],"balance_after":107800,"source":{"system":"sec-edgar","filing":"0001209191-21-034929","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919121034929/doc4.xml","form_type":"4"}},{"id":2700985,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-05-21T20:34:09.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":8249,"price":13.4232,"value":110727.9768,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $12.69 to $13.66, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents shares held directly by an irrevocable family trust having an independent trustee."}],"balance_after":108533,"source":{"system":"sec-edgar","filing":"0001209191-21-034929","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919121034929/doc4.xml","form_type":"4"}},{"id":2700984,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-05-21T20:34:09.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":612,"price":13.7277,"value":8401.3524,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $13.69 to $13.79, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents shares held directly by an irrevocable family trust having an independent trustee."}],"balance_after":89809,"source":{"system":"sec-edgar","filing":"0001209191-21-034929","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919121034929/doc4.xml","form_type":"4"}},{"id":2700983,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-05-21T20:34:09.000Z","date":"2021-05-19","kind":"sale","acquired":false,"shares":6872,"price":13.4232,"value":92244.2304,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $12.69 to $13.66, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents shares held directly by an irrevocable family trust having an independent trustee."}],"balance_after":90421,"source":{"system":"sec-edgar","filing":"0001209191-21-034929","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919121034929/doc4.xml","form_type":"4"}},{"id":2723244,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-05-07T20:02:42.000Z","date":"2021-05-05","kind":"sale","acquired":false,"shares":3670,"price":14.7006,"value":53951.202,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $14.53 to $15.04, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents shares held directly by an irrevocable family trust having an independent trustee."}],"balance_after":116782,"source":{"system":"sec-edgar","filing":"0001209191-21-030874","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919121030874/doc4.xml","form_type":"4"}},{"id":2723243,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-05-07T20:02:42.000Z","date":"2021-05-05","kind":"sale","acquired":false,"shares":5312,"price":13.8957,"value":73813.9584,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $13.51 to $14.48, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents shares held directly by an irrevocable family trust having an independent trustee."}],"balance_after":120452,"source":{"system":"sec-edgar","filing":"0001209191-21-030874","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919121030874/doc4.xml","form_type":"4"}},{"id":2723242,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-05-07T20:02:42.000Z","date":"2021-05-05","kind":"sale","acquired":false,"shares":3058,"price":14.7006,"value":44954.4348,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $14.53 to $15.04, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents shares held directly by an irrevocable family trust having an independent trustee."}],"balance_after":97293,"source":{"system":"sec-edgar","filing":"0001209191-21-030874","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919121030874/doc4.xml","form_type":"4"}},{"id":2723241,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-05-07T20:02:42.000Z","date":"2021-05-05","kind":"sale","acquired":false,"shares":4426,"price":13.8957,"value":61502.3682,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $13.51 to $14.48, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents shares held directly by an irrevocable family trust having an independent trustee."}],"balance_after":100351,"source":{"system":"sec-edgar","filing":"0001209191-21-030874","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000120919121030874/doc4.xml","form_type":"4"}},{"id":2742052,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-22T20:34:40.000Z","date":"2021-04-20","kind":"sale","acquired":false,"shares":7484,"price":12.0051,"value":89846.1684,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $11.76 to $12.27, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents 104,777 shares held directly by an irrevocable family trust having an independent trustee."}],"balance_after":104777,"source":{"system":"sec-edgar","filing":"0000899243-21-016753","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924321016753/doc4.xml","form_type":"4"}},{"id":2742051,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-22T20:34:40.000Z","date":"2021-04-20","kind":"sale","acquired":false,"shares":8982,"price":12.0051,"value":107829.8082,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $11.76 to $12.27, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents 125,764 shares held directly by an irrevocable family trust having an independent trustee."}],"balance_after":125764,"source":{"system":"sec-edgar","filing":"0000899243-21-016753","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924321016753/doc4.xml","form_type":"4"}},{"id":2752990,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-08T20:37:03.000Z","date":"2021-04-06","kind":"sale","acquired":false,"shares":7484,"price":13.039,"value":97583.876,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $12.61 to $13.38, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents 112,261 shares held directly by an irrevocable family trust having an independent trustee."}],"balance_after":112261,"source":{"system":"sec-edgar","filing":"0000899243-21-015390","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924321015390/doc4.xml","form_type":"4"}},{"id":2752989,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-08T20:37:03.000Z","date":"2021-04-06","kind":"sale","acquired":false,"shares":8982,"price":13.039,"value":117116.298,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $12.61 to $13.38, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents 134,746 shares held directly by an irrevocable family trust having an independent trustee."}],"balance_after":134746,"source":{"system":"sec-edgar","filing":"0000899243-21-015390","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924321015390/doc4.xml","form_type":"4"}},{"id":2764429,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-01T22:48:24.000Z","date":"2021-03-30","kind":"sale","acquired":false,"shares":4500,"price":13.22,"value":59490.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $12.93 to $13.62, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents 119,745 shares held directly by an irrevocable family trust having an independent trustee."}],"balance_after":119745,"source":{"system":"sec-edgar","filing":"0000899243-21-014405","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924321014405/doc4.xml","form_type":"4"}},{"id":2764428,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-01T22:48:24.000Z","date":"2021-03-30","kind":"sale","acquired":false,"shares":5400,"price":13.22,"value":71388.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $11.88 to $12.87, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents 143,728 shares held directly by an irrevocable family trust having an independent trustee."}],"balance_after":143728,"source":{"system":"sec-edgar","filing":"0000899243-21-014405","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924321014405/doc4.xml","form_type":"4"}},{"id":2764427,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-01T22:48:24.000Z","date":"2021-03-30","kind":"sale","acquired":false,"shares":2984,"price":12.3,"value":36703.2,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $12.93 to $13.62, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents 119,745 shares held directly by an irrevocable family trust having an independent trustee."}],"balance_after":124245,"source":{"system":"sec-edgar","filing":"0000899243-21-014405","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924321014405/doc4.xml","form_type":"4"}},{"id":2764426,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-01T22:48:24.000Z","date":"2021-03-30","kind":"sale","acquired":false,"shares":3582,"price":12.3,"value":44058.6,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $11.88 to $12.87, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents 143,728 shares held directly by an irrevocable family trust having an independent trustee."}],"balance_after":149128,"source":{"system":"sec-edgar","filing":"0000899243-21-014405","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924321014405/doc4.xml","form_type":"4"}},{"id":2764425,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-01T22:43:29.000Z","date":"2021-01-25","kind":"gift","acquired":false,"shares":27014,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F10","text":"Represents 27,014 shares transferred by gift by a grantor retained annuity trust of which the Reporting Person is the trustee to an irrevocable family trust having an independent trustee. The transaction is reportable on Form 5, but the Reporting Person is voluntarily reporting early on Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Represents 27,014 shares transferred by gift by a grantor retained annuity trust of which the Reporting Person is the trustee to an irrevocable family trust having an independent trustee. The transaction is reportable on Form 5, but the Reporting Person is voluntarily reporting early on Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Represents 27,014 shares transferred by gift by a grantor retained annuity trust of which the Reporting Person is the trustee to an irrevocable family trust having an independent trustee. The transaction is reportable on Form 5, but the Reporting Person is voluntarily reporting early on Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-014399","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924321014399/doc4a.xml","form_type":"4/A","original_submission_date":"2021-03-18"}},{"id":2764424,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-01T22:43:29.000Z","date":"2021-01-25","kind":"gift","acquired":false,"shares":19286,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F9","text":"Represents 19,286 shares transferred by gift by a grantor retained annuity trust of which the Reporting Person's spouse is the trustee to an irrevocable family trust having an independent trustee. The transaction is reportable on Form 5, but the Reporting Person is voluntarily reporting early on Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents 19,286 shares transferred by gift by a grantor retained annuity trust of which the Reporting Person's spouse is the trustee to an irrevocable family trust having an independent trustee. The transaction is reportable on Form 5, but the Reporting Person is voluntarily reporting early on Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Represents 19,286 shares transferred by gift by a grantor retained annuity trust of which the Reporting Person's spouse is the trustee to an irrevocable family trust having an independent trustee. The transaction is reportable on Form 5, but the Reporting Person is voluntarily reporting early on Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-014399","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924321014399/doc4a.xml","form_type":"4/A","original_submission_date":"2021-03-18"}},{"id":2764423,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-01T22:43:29.000Z","date":"2021-01-22","kind":"gift","acquired":false,"shares":23570,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F8","text":"Represents 23,570 shares transferred by gift by a revocable family trust of which the Reporting Person is the trustee to an irrevocable family trust having an independent trustee. The transaction is reportable on Form 5, but the Reporting Person is voluntarily reporting early on Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents 23,570 shares transferred by gift by a revocable family trust of which the Reporting Person is the trustee to an irrevocable family trust having an independent trustee. The transaction is reportable on Form 5, but the Reporting Person is voluntarily reporting early on Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Represents 23,570 shares transferred by gift by a revocable family trust of which the Reporting Person is the trustee to an irrevocable family trust having an independent trustee. The transaction is reportable on Form 5, but the Reporting Person is voluntarily reporting early on Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-014399","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924321014399/doc4a.xml","form_type":"4/A","original_submission_date":"2021-03-18"}},{"id":2764422,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-01T22:43:29.000Z","date":"2021-01-22","kind":"gift","acquired":false,"shares":22985,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"Represents 22,985 shares transferred by gift by a revocable family trust of which the Reporting Person is the trustee to an irrevocable family trust having an independent trustee. The transaction is reportable on Form 5, but the Reporting Person is voluntarily reporting early on Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents 22,985 shares transferred by gift by a revocable family trust of which the Reporting Person is the trustee to an irrevocable family trust having an independent trustee. The transaction is reportable on Form 5, but the Reporting Person is voluntarily reporting early on Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Represents 22,985 shares transferred by gift by a revocable family trust of which the Reporting Person is the trustee to an irrevocable family trust having an independent trustee. The transaction is reportable on Form 5, but the Reporting Person is voluntarily reporting early on Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-014399","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924321014399/doc4a.xml","form_type":"4/A","original_submission_date":"2021-03-18"}},{"id":2764421,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-01T22:43:29.000Z","date":"2021-01-22","kind":"gift","acquired":false,"shares":26070,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Represents 26,070 shares transferred by gift by the Reporting Person to an irrevocable family trust having an independent trustee. The transaction is reportable on Form 5, but the Reporting Person is voluntarily reporting early on Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents 26,070 shares transferred by gift by the Reporting Person to an irrevocable family trust having an independent trustee. The transaction is reportable on Form 5, but the Reporting Person is voluntarily reporting early on Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Represents 26,070 shares transferred by gift by the Reporting Person to an irrevocable family trust having an independent trustee. The transaction is reportable on Form 5, but the Reporting Person is voluntarily reporting early on Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-014399","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924321014399/doc4a.xml","form_type":"4/A","original_submission_date":"2021-03-18"}},{"id":2764420,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-01T22:43:29.000Z","date":"2021-03-16","kind":"sale","acquired":false,"shares":2089,"price":15.66,"value":32713.74,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $15.50 to $16.02, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents 127,229 shares held directly by an irrevocable family trust having an independent trustee."}],"balance_after":127229,"source":{"system":"sec-edgar","filing":"0000899243-21-014399","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924321014399/doc4a.xml","form_type":"4/A","original_submission_date":"2021-03-18"}},{"id":2764419,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-01T22:43:29.000Z","date":"2021-03-16","kind":"sale","acquired":false,"shares":2508,"price":15.07,"value":37795.56,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $14.49 to $15.48, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents 152,710 shares held directly by an irrevocable family trust having an independent trustee."}],"balance_after":152710,"source":{"system":"sec-edgar","filing":"0000899243-21-014399","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924321014399/doc4a.xml","form_type":"4/A","original_submission_date":"2021-03-18"}},{"id":2764418,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-01T22:43:29.000Z","date":"2021-03-16","kind":"sale","acquired":false,"shares":5395,"price":15.66,"value":84485.7,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $15.50 to $16.02, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents 127,229 shares held directly by an irrevocable family trust having an independent trustee."}],"balance_after":129318,"source":{"system":"sec-edgar","filing":"0000899243-21-014399","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924321014399/doc4a.xml","form_type":"4/A","original_submission_date":"2021-03-18"}},{"id":2764417,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-01T22:43:29.000Z","date":"2021-03-16","kind":"sale","acquired":false,"shares":6474,"price":15.07,"value":97563.18,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $14.49 to $15.48, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents 152,710 shares held directly by an irrevocable family trust having an independent trustee."}],"balance_after":155218,"source":{"system":"sec-edgar","filing":"0000899243-21-014399","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924321014399/doc4a.xml","form_type":"4/A","original_submission_date":"2021-03-18"}},{"id":2764430,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-01T22:40:35.000Z","date":"2020-10-23","kind":"tax_withholding","acquired":false,"shares":8649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person is disposing of 8,649 restricted stock units as a result of a revised tax rate for such restricted stock units."}],"balance_after":26070,"source":{"system":"sec-edgar","filing":"0000899243-21-014397","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924321014397/doc4a.xml","form_type":"4/A","original_submission_date":"2020-10-23"}},{"id":2779434,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-03-19T01:55:17.000Z","date":"2021-03-16","kind":"sale","acquired":false,"shares":2089,"price":15.66,"value":32713.74,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $15.50 to $16.02, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents 127,229 shares held directly by an irrevocable family trust having an independent trustee."}],"balance_after":127229,"source":{"system":"sec-edgar","filing":"0000899243-21-012698","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924321012698/doc4.xml","form_type":"4"}},{"id":2779433,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-03-19T01:55:17.000Z","date":"2021-03-16","kind":"sale","acquired":false,"shares":2508,"price":15.07,"value":37795.56,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $14.49 to $15.48, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents 152,710 shares held directly by an irrevocable family trust having an independent trustee."}],"balance_after":152710,"source":{"system":"sec-edgar","filing":"0000899243-21-012698","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924321012698/doc4.xml","form_type":"4"}},{"id":2779432,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-03-19T01:55:17.000Z","date":"2021-03-16","kind":"sale","acquired":false,"shares":5395,"price":15.66,"value":84485.7,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $15.50 to $16.02, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents 127,229 shares held directly by an irrevocable family trust having an independent trustee."}],"balance_after":129318,"source":{"system":"sec-edgar","filing":"0000899243-21-012698","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924321012698/doc4.xml","form_type":"4"}},{"id":2779431,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-03-19T01:55:17.000Z","date":"2021-03-16","kind":"sale","acquired":false,"shares":6474,"price":15.07,"value":97563.18,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $14.49 to $15.48, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents 152,710 shares held directly by an irrevocable family trust having an independent trustee."}],"balance_after":155218,"source":{"system":"sec-edgar","filing":"0000899243-21-012698","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924321012698/doc4.xml","form_type":"4"}},{"id":2855013,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":35993,"kind":"person","name":"Schor Chen","position":1,"cik":"0001340875","reported_name":"Schor Chen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-18T02:08:07.000Z","date":"2021-02-12","kind":"grant","acquired":true,"shares":421600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares shall vest on each of the next forty-eight (48) monthly anniversaries of the Vesting Commencement date, provided that the Reporting Person remains in continuous service as of the applicable vesting dates."}],"balance_after":421600,"derivative":{"exercise_price":16.82,"expiration_date":"2031-02-11","underlying":"Common Stock","underlying_shares":421600},"source":{"system":"sec-edgar","filing":"0000899243-21-007022","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924321007022/doc4.xml","form_type":"4"}}],"next_cursor":"2021-02-18T02:08:07.000000Z,2855013"}